Monetary Management Group Lowered Apple Com (AAPL) Holding, Cytomx Therapeutics (CTMX) Shorts Decreased By 0.41%

June 19, 2017 - By Adrian Mccoy

Cytomx Therapeutics Incorporated (NASDAQ:CTMX) had a decrease of 0.41% in short interest. CTMX’s SI was 770,600 shares in June as released by FINRA. Its down 0.41% from 773,800 shares previously. With 179,200 avg volume, 4 days are for Cytomx Therapeutics Incorporated (NASDAQ:CTMX)’s short sellers to cover CTMX’s short positions. The SI to Cytomx Therapeutics Incorporated’s float is 3.72%. About 173,938 shares traded or 2.38% up from the average. CytomX Therapeutics Inc (NASDAQ:CTMX) has risen 50.10% since June 19, 2016 and is uptrending. It has outperformed by 33.40% the S&P500.

Monetary Management Group Inc decreased Apple Inc Com (AAPL) stake by 11.48% reported in 2016Q4 SEC filing. Monetary Management Group Inc sold 9,245 shares as Apple Inc Com (AAPL)’s stock rose 12.78%. The Monetary Management Group Inc holds 71,298 shares with $8.26M value, down from 80,543 last quarter. Apple Inc Com now has $753.52 billion valuation. The stock rose 3.03% or $4.3 reaching $146.57. About 19.11M shares traded. Apple Inc. (NASDAQ:AAPL) has risen 62.48% since June 19, 2016 and is uptrending. It has outperformed by 45.78% the S&P500.

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The company has market cap of $526.12 million. The Firm uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as well as to develop cancer therapeutics against difficult-to-drug targets. It currently has negative earnings. The Company’s pipeline is focused on the development of therapies in a set of modalities: Probody cancer immunotherapies, Probody drug conjugates, T-cell engaging Probody bispecifics and ProCAR-NK cell therapies.

Among 3 analysts covering CytomX Therapeutics (NASDAQ:CTMX), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. CytomX Therapeutics had 4 analyst reports since November 2, 2015 according to SRatingsIntel. The stock has “Buy” rating by Jefferies on Monday, November 2. The company was initiated on Monday, November 2 by Oppenheimer. The rating was initiated by Cowen & Co on Monday, November 2 with “Outperform”. Oppenheimer downgraded the stock to “Perform” rating in Tuesday, January 3 report.

Among 45 analysts covering Apple Inc. (NASDAQ:AAPL), 35 have Buy rating, 1 Sell and 9 Hold. Therefore 78% are positive. Apple Inc. had 214 analyst reports since July 21, 2015 according to SRatingsIntel. Canaccord Genuity maintained it with “Buy” rating and $146.0 target in Friday, January 8 report. Piper Jaffray maintained it with “Overweight” rating and $172 target in Friday, August 14 report. The stock of Apple Inc. (NASDAQ:AAPL) has “Buy” rating given on Wednesday, October 28 by Susquehanna. On Friday, September 11 the stock rating was maintained by BMO Capital Markets with “Buy”. The stock has “Neutral” rating by Rosenblatt on Wednesday, January 6. On Monday, January 11 the stock rating was maintained by Deutsche Bank with “Hold”. The firm has “Outperform” rating by Oppenheimer given on Monday, January 11. The rating was maintained by Cowen & Co with “Market Perform” on Friday, September 11. On Friday, September 11 the stock rating was maintained by Robert W. Baird with “Buy”. The firm has “Buy” rating given on Wednesday, October 12 by Goldman Sachs.

Since December 27, 2016, it had 0 insider purchases, and 32 insider sales for $162.84 million activity. COOK TIMOTHY D also sold $1.10 million worth of Apple Inc. (NASDAQ:AAPL) shares. $1.53M worth of Apple Inc. (NASDAQ:AAPL) shares were sold by Srouji Johny. On Thursday, February 16 FEDERIGHI CRAIG sold $9.56 million worth of Apple Inc. (NASDAQ:AAPL) or 70,627 shares. Shares for $2.95M were sold by Maestri Luca. 35,000 shares were sold by LEVINSON ARTHUR D, worth $5.39 million. The insider Riccio Daniel J. sold $1.86M. The insider Cue Eduardo H sold 45,000 shares worth $6.92M.

Investors sentiment decreased to 0.79 in Q4 2016. Its down 0.03, from 0.82 in 2016Q3. It dropped, as 90 investors sold AAPL shares while 975 reduced holdings. 123 funds opened positions while 723 raised stakes. 3.04 billion shares or 1.85% more from 2.98 billion shares in 2016Q3 were reported. 658 are held by Weaver C Barksdale And Assoc. 37,465 are held by Ghp Invest. Cim Investment Mangement Inc holds 1.7% in Apple Inc. (NASDAQ:AAPL) or 40,347 shares. Amg Natl Retail Bank owns 0.07% invested in Apple Inc. (NASDAQ:AAPL) for 7,503 shares. Ingalls And Snyder Limited Liability Company has 194,308 shares. Riverbridge Ptnrs reported 0.1% of its portfolio in Apple Inc. (NASDAQ:AAPL). Rand Wealth Ltd Liability Co holds 1.37% or 93,716 shares in its portfolio. Quest Invest Incorporated Or accumulated 211,672 shares. Alexandria Lc accumulated 84,370 shares. Bluefin Trading Lc has 36,446 shares. Spectrum Gru Incorporated reported 10,994 shares. Research invested 0.83% in Apple Inc. (NASDAQ:AAPL). Endowment Mngmt L P, a North Carolina-based fund reported 3,070 shares. Clal Insur Enter Limited reported 0.03% stake. Jane Street Group Llc invested 0.28% of its portfolio in Apple Inc. (NASDAQ:AAPL).

Analysts await Apple Inc. (NASDAQ:AAPL) to report earnings on July, 25. They expect $1.57 earnings per share, up 10.56% or $0.15 from last year’s $1.42 per share. AAPL’s profit will be $8.07B for 23.34 P/E if the $1.57 EPS becomes a reality. After $2.10 actual earnings per share reported by Apple Inc. for the previous quarter, Wall Street now forecasts -25.24% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: